Federated Hermes, Inc. Amgen Inc Transaction History

Federated Hermes, Inc.

$41.2 Billion
Q2 2024

A detailed history of Federated Hermes, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,317,438 shares of AMGN stock, worth $425 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

1,317,438

Previous 1,471,927 10.5%

Holding current value

$425 Million

Previous $418 Million 1.64%

% of portfolio

1.0%

Previous 0.98%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$262.75 - $319.31 $40.6 Million - $49.3 Million	-154,489 Reduced 10.5%	1,317,438 $412 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $71.7 Million - $86.6 Million	-266,768 Reduced 15.34%	1,471,927 $418 Million
Q4 2023 Jan 31, 2024	SELL	$255.7 - $288.46 $195 Million - $220 Million	-760,949 Reduced 30.44%	1,738,695 $501 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $5.69 Million - $7.07 Million	26,045 Added 1.05%	2,499,644 $672 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $164 Million - $194 Million	767,581 Added 44.99%	2,473,599 $549 Million
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $82.6 Million - $101 Million	366,044 Added 27.32%	1,706,018 $412 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $181 Million - $230 Million	-788,748 Reduced 37.05%	1,339,974 $352 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $66.8 Million - $75.3 Million	297,558 Added 16.25%	2,128,722 $480 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $79.9 Million - $88.9 Million	346,190 Added 23.31%	1,831,164 $446 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $12.8 Million - $14.2 Million	-58,433 Reduced 3.79%	1,484,974 $359 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $48.4 Million - $55.4 Million	243,451 Added 18.73%	1,543,407 $347 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $80.9 Million - $94.8 Million	381,161 Added 41.48%	1,299,956 $276 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $419,976 - $465,933	1,798 Added 0.2%	918,795 $224 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $4.4 Million - $5.13 Million	-19,819 Reduced 2.12%	916,997 $228 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $3.37 Million - $4.01 Million	-15,572 Reduced 1.64%	936,816 $215 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $4.02 Million - $4.47 Million	-17,147 Reduced 1.77%	952,388 $242 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $9.2 Million - $11.3 Million	-46,524 Reduced 4.58%	969,535 $229 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $22.6 Million - $30 Million	-124,054 Reduced 10.88%	1,016,059 $206 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $155 Million - $199 Million	819,628 Added 255.75%	1,140,113 $275 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $356,403 - $427,045	-2,047 Reduced 0.63%	320,485 $62 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $299,893 - $351,542	1,799 Added 0.56%	322,532 $59.4 Million
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $5.76 Million - $6.49 Million	-31,848 Reduced 9.03%	320,733 $60.9 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $39,426 - $46,023	-221 Reduced 0.06%	352,581 $68.6 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $48.9 Million - $55.1 Million	263,736 Added 296.11%	352,802 $73.1 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $19.7 Million - $22.1 Million	-118,487 Reduced 57.09%	89,066 $16.4 Million
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $682,294 - $797,346	-4,027 Reduced 1.9%	207,553 $35.4 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $2.3 Million - $2.57 Million	13,648 Added 6.9%	211,580 $0
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $33.1 Million - $37.8 Million	197,932	197,932 $36.9 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Amgen Inc Transaction History